🌼 Sublingual Immunotherapy Tablet Simulator

Placing the Allergen Tablet Under the Tongue

Placeholder: a fast-dissolving tablet is tucked under the tongue daily.

• Daily: Dosing frequency (Placeholder: once-daily home dosing.)
• ~2 min: Hold time (Placeholder: tablet held before swallowing.)
• Grass, dust, ragweed: Allergen types (Placeholder: common extract targets.)
• Clinic-observed: First dose setting (Placeholder: first dose under supervision.)

Why sublingual placement

Placeholder: sublingual site chosen for rich vascularity and easy access.

Extract Absorption Through Sublingual Mucosa

Placeholder: dissolved allergen diffuses through thin sublingual tissue.

• Thin: Mucosa thickness (Placeholder: favors rapid extract diffusion.)
• <3 min: Dissolve time (Placeholder: tablet fully dissolves quickly.)
• High: Blood supply (Placeholder: sublingual area is highly vascular.)
• Low: Systemic exposure (Placeholder: limited compared to injections.)

Absorption pathway

Placeholder: extract passes epithelium into local immune tissue.

Dendritic Cells Sample Antigen Tolerogenically

Placeholder: local dendritic cells capture antigen and induce tolerance.

• Dendritic cells: Cell type (Placeholder: oral mucosa resident antigen cells.)
• Tolerogenic: Response bias (Placeholder: favors regulatory T-cell induction.)
• IL-10 / TGF-β: Key cytokine (Placeholder: regulatory signaling molecules.)
• Hours: Time to signal (Placeholder: sampling begins within hours.)

Tolerance induction mechanism

Placeholder: regulatory T-cells expand, dampening allergic response.

Self-Administration Convenience at Home

Placeholder: patients dose themselves without repeated clinic visits.

• 1–2: Clinic visits/yr (Placeholder: far fewer than injection therapy.)
• None: Needle use (Placeholder: no injections required at home.)
• Moderate: Adherence challenge (Placeholder: daily habit needed for years.)
• Room temp: Storage (Placeholder: tablets stored without refrigeration.)

Convenience trade-offs

Placeholder: convenience depends on sustained daily adherence.

SLIT Tablets vs Subcutaneous Injection Immunotherapy

Placeholder: multi-year SLIT trials show efficacy near SCIT injections.

• Comparable: Symptom relief (Placeholder: similar long-term symptom scores.)
• Lower: Systemic reaction risk (Placeholder: fewer severe reactions than injections.)
• 3 years: Course length (Placeholder: typical recommended treatment duration.)
• Rare: Anaphylaxis risk (Placeholder: lower than subcutaneous route.)

Choosing between routes

Placeholder: SLIT trades clinic-based potency for home convenience.

Placeholder: both routes can achieve durable allergen tolerance.